From 2008.igem.org
(Difference between revisions)
|
|
| (6 intermediate revisions not shown) |
| Line 1: |
Line 1: |
| - | {{Paris/Menu}}
| + | delete |
| - | | + | |
| - | =='''Synchronization'''==
| + | |
| - | | + | |
| - | ===First Model===
| + | |
| - | [[image:Synchro1.jpg|500px]]
| + | |
| - | | + | |
| - | Strain : double mutant ΔflhDC and ΔflgM
| + | |
| - | | + | |
| - | Designed plasmids
| + | |
| - | {| border="1"
| + | |
| - | |align="center"|Generic Name
| + | |
| - | |align="center"|Construction
| + | |
| - | |align="center"|Advancement
| + | |
| - | |-
| + | |
| - | |align="center"|FlhDC
| + | |
| - | |align="center"|pTet - FlhDC
| + | |
| - | |align="center"|☣
| + | |
| - | |-
| + | |
| - | |align="center"|AHL enzyme
| + | |
| - | |align="center"|pFliL - LasI
| + | |
| - | |align="center"|☣
| + | |
| - | |-
| + | |
| - | |align="center"|AHL Receptor
| + | |
| - | |align="center"|pConstitutive - LasR
| + | |
| - | |align="center"|☣
| + | |
| - | |-
| + | |
| - | |align="center"|FlhDC Inhibitor
| + | |
| - | |align="center"|pLas - TetR - RFP
| + | |
| - | |align="center"|☣
| + | |
| - | |}
| + | |
| - | | + | |
| - | | + | |
| - | | + | |
| - | ===Second Model===
| + | |
| - | | + | |
| - | | + | |
| - | | + | |
| - | [[image:Synchro2.jpg|500px]]
| + | |
| - | | + | |
| - | | + | |
| - | Strain : mutant ΔflgM
| + | |
| - | | + | |
| - | Designed plasmids
| + | |
| - | {| border="1"
| + | |
| - | |align="center"|Generic Name
| + | |
| - | |align="center"|Construction
| + | |
| - | |align="center"|Advancement
| + | |
| - | |-
| + | |
| - | |align="center"|Reporter
| + | |
| - | |align="center"|pFliL - LasI - GFP
| + | |
| - | |align="center"|☣
| + | |
| - | |-
| + | |
| - | |align="center"|AHL Receptor
| + | |
| - | |align="center"|pConstitutive - LasR
| + | |
| - | |align="center"|☣
| + | |
| - | |-
| + | |
| - | |align="center"|FlhDC Inhibitor
| + | |
| - | |align="center"|pLas - TetR - RFP
| + | |
| - | |align="center"|☣
| + | |
| - | |}
| + | |
Latest revision as of 11:05, 28 August 2008
delete
"
